Ahead of the crucial 11th round of talks aimed at ending the trade war between the world's two largest economies, scheduled for May 9-10 in Washington, China has said it will retaliate if US raises tariffs on Chinese products.
China has threatened to take retaliatory measures if Trump raises tariffs on $200 billion worth of goods ahead of the crucial 11th round of talks aimed at ending the trade war between the world's two largest economies.
Markets have been rattled ever since US President Donald Trump on Sunday threatened to hike tariffs on USD 200 billion worth of Chinese goods this week.
The net proceeds from the fresh issue, the company has proposed, be utilised for prepayment or repayment of loans, long-term working capital and general corporate purposes.
Alembic Pharma has signed a joint venture with SPH SINE Pharmaceutical Laboratories Co Ltd and Adia (Shanghai) Pharmaceuticals Co Ltd to promote and sell pharmaceutical products for the Chinese market.
The DHFL stock was trading at Rs 115.90, down 0.6%, at 2:05pm on BSE.
Zee Entertainment had announced in November last year that its promoters, led-by Subhash Chandra, planned to sell up to 50% of their stake in the company to a strategic partner.
RBI had cut interest rate by 25 basis points each in February and April to boost economic growth.The 30-share index was trading 205.12 points, or 0.54 per cent, lower at 38,071.51.Forex traders said, besides the US-China trade concerns, foreign fund outflows, heavy selling in domestic equities and rising crude oil prices also kept pressure on the Indian rupee.
ITR forms are taxpayers statement detailing his/her earnings regular income (wages), interest, dividends, capital gains, or other profits, the total tax paid on earnings and the appropriate refunds to be repaid to him/her by the government.
American companies are showing goodwill and cooperative attitude towards Make in India and the other programs, but there is a limit to the discriminatory behaviour, US commerce secretary Wilbur Ross said.
Ayogya is powerful in its persuasive tempo and almost a frantic attempt to keep our attention from straying.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla elementum viverra pharetra. Nulla facilisis, sapien non pharetra venenatis, tortor erat tempus est, sed accumsan odio ante ac elit./p>
